Background Neuroendocrine carcinoma of the cervix (NECC) is a rare variant of cervical
cancer. The prognosis of women with NECC is poor and there is no standardized therapy for …

Neuroendocrine carcinomas of the cervix account for less than 2% of all invasive cervical
cancers and are classified as low-grade (carcinoid, atypical carcinoid tumor) or high-grade …

High-grade neuroendocrine neoplasms are a rare disease entity and account for
approximately 10% of all neuroendocrine neoplasms. Because of their rarity, there is an …

Background High-grade neuroendocrine carcinomas (HGNECs) of the colon and rectum are
rare, constituting less than 1% of colorectal cancers. The purpose of this study was to identify …

Small cell carcinoma of the cervix (SCCC) is a rare histological entity of uterine cervical
cancer. Compared with other common histological types, squamous cell carcinoma or …

Neuroendocrine carcinoma of the cervix is an ultra‐rare malignancy with a poor prognosis
and limited treatment options. Checkpoint blockade immunotherapy has rapidly developed …

BACKGROUND: Our aims were to investigate the treatment and clinicopathological
variables in relation to prognosis in small cell neuroendocrine cervical carcinoma …

Objective Neuroendocrine carcinomas of the cervix (NECC) are rare and thought to be
aggressive. We performed a population-based analysis to examine the natural history …

Abstract Objective Small cell carcinoma (SmCC) of the female genital tract constitutes a
diagnostic and clinical challenge given its rarity and the lack of standardized therapeutic …

Objective To investigate the efficacy and safety of pembrolizumab in women with recurrent
small cell neuroendocrine tumors of the lower genital tract. Methods We conducted an open …